Literature DB >> 32934043

Sarcopenia in cirrhosis: A practical overview.

Amritpal Dhaliwal1, Matthew J Armstrong2.   

Abstract

Patients with liver cirrhosis and, in particular, those with liver failure are at high risk of reduced muscle mass and strength/function, otherwise known as sarcopenia. Sarcopenia is a complex, multifactorial (poor nutritional intake, protein catabolism, physical inactivity) chronic condition, which increases the risk of liver-related morbidity and mortality. Early recognition and tailored management incorporating high protein diets and combination aerobic/resistance exercise can ameliorate the complications associated with sarcopenia in cirrhosis. This review provides an overview of the epidemiology, pathogenesis, assessment tools and management of sarcopenia in cirrhosis. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  Sarcopenia; cirrhosis; liver failure; muscle; nutrition

Mesh:

Year:  2020        PMID: 32934043      PMCID: PMC7539699          DOI: 10.7861/clinmed.2020-0089

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  20 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

2.  Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK.

Authors:  Roger Williams; Graeme Alexander; Richard Aspinall; Rachel Batterham; Neeraj Bhala; Nick Bosanquet; Katherine Severi; Anya Burton; Robyn Burton; Matthew E Cramp; Natalie Day; Anil Dhawan; John Dillon; Colin Drummond; Jessica Dyson; James Ferguson; Graham R Foster; Ian Gilmore; Jonny Greenberg; Clive Henn; Mark Hudson; Helen Jarvis; Deirdre Kelly; Jake Mann; Neil McDougall; Martin McKee; Kieran Moriarty; Joanne Morling; Philip Newsome; John O'Grady; Liz Rolfe; Peter Rice; Harry Rutter; Nick Sheron; Douglas Thorburn; Julia Verne; Jyotsna Vohra; John Wass; Andrew Yeoman
Journal:  Lancet       Date:  2018-11-22       Impact factor: 79.321

3.  Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.

Authors:  Puneeta Tandon; Michael Ney; Ivana Irwin; Mang M Ma; Leah Gramlich; Vincent G Bain; Nina Esfandiari; Vickie Baracos; Aldo J Montano-Loza; Robert P Myers
Journal:  Liver Transpl       Date:  2012-10       Impact factor: 5.799

4.  Nutrition in liver cirrhosis: a case-based overview.

Authors:  Amritpal Dhaliwal; Jennifer Towey; Janet M Lord; Matthew Armstrong; Ahmed Mohamed Elsharkawy
Journal:  Frontline Gastroenterol       Date:  2019-09-10

Review 5.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

6.  Continued muscle loss increases mortality in cirrhosis: Impact of aetiology of liver disease.

Authors:  Nicole Welch; Jaividhya Dasarathy; Ashok Runkana; Revathi Penumatsa; Annette Bellar; Jaspreet Reen; Daniel Rotroff; Arthur J McCullough; Srinivasan Dasarathy
Journal:  Liver Int       Date:  2020-01-26       Impact factor: 5.828

Review 7.  Sarcopenia from mechanism to diagnosis and treatment in liver disease.

Authors:  Srinivasan Dasarathy; Manuela Merli
Journal:  J Hepatol       Date:  2016-08-08       Impact factor: 25.083

Review 8.  Exercise in cirrhosis: Translating evidence and experience to practice.

Authors:  Puneeta Tandon; Kathleen Patricia Ismond; Kenneth Riess; Andres Duarte-Rojo; Bandar Al-Judaibi; Michael Andrew Dunn; Jennifer Holman; Nancy Howes; Mark Joseph Franklin Haykowsky; Deborah Ann Josbeno; Margaret McNeely
Journal:  J Hepatol       Date:  2018-06-30       Impact factor: 25.083

Review 9.  Sarcopenia in cirrhosis: from pathogenesis to interventions.

Authors:  Maryam Ebadi; Rahima A Bhanji; Vera C Mazurak; Aldo J Montano-Loza
Journal:  J Gastroenterol       Date:  2019-08-07       Impact factor: 7.527

10.  A Model to Identify Sarcopenia in Patients With Cirrhosis.

Authors:  Puneeta Tandon; Gavin Low; Marina Mourtzakis; Laura Zenith; Robert P Myers; Juan G Abraldes; Abdel Aziz M Shaheen; Hina Qamar; Nadia Mansoor; Michelle Carbonneau; Kathleen Ismond; Sumeer Mann; Alshimaa Alaboudy; Mang Ma
Journal:  Clin Gastroenterol Hepatol       Date:  2016-05-14       Impact factor: 11.382

View more
  5 in total

1.  Effects of Branched-Chain Amino Acids on Parameters Evaluating Sarcopenia in Liver Cirrhosis: Systematic Review and Meta-Analysis.

Authors:  Abdulrahman Ismaiel; Camelia Bucsa; Andreea Farcas; Daniel-Corneliu Leucuta; Stefan-Lucian Popa; Dan L Dumitrascu
Journal:  Front Nutr       Date:  2022-01-27

Review 2.  Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives.

Authors:  Diego García-Compeán; Emanuela Orsi; Ramesh Kumar; Felix Gundling; Tsutomu Nishida; Jesús Zacarías Villarreal-Pérez; Ángel N Del Cueto-Aguilera; José A González-González; Giuseppe Pugliese
Journal:  World J Gastroenterol       Date:  2022-02-28       Impact factor: 5.742

3.  Assessment of Sarcopenia Related Quality of Life Using SarQoL® Questionnaire in Patients With Liver Cirrhosis.

Authors:  Speranta Iacob; Victor Mina; Matei Mandea; Razvan Iacob; Roxana Vadan; Voichita Boar; Georgeta Ionescu; Dan Buzescu; Cristian Gheorghe; Liana Gheorghe
Journal:  Front Nutr       Date:  2022-02-25

Review 4.  Sarcopenia in Inflammatory Bowel Disease: A Narrative Overview.

Authors:  Amritpal Dhaliwal; Jonathan I Quinlan; Kellie Overthrow; Carolyn Greig; Janet M Lord; Matthew J Armstrong; Sheldon C Cooper
Journal:  Nutrients       Date:  2021-02-17       Impact factor: 5.717

Review 5.  Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies.

Authors:  Annalisa Cespiati; Marica Meroni; Rosa Lombardi; Giovanna Oberti; Paola Dongiovanni; Anna Ludovica Fracanzani
Journal:  Biomedicines       Date:  2022-01-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.